Abstract
Essential thrombocytosis is extremely rare in children. However, when present, it is associated with increased prevalence of antiphospholipid antibodies and thrombo-hemorrhagic complications. The authors report here a child with Budd-Chiari Syndrome resulting from essential thrombocytosis and associated antiphospholipid antibodies. A 13- y-old boy presented with microcytic hypochromic anemia, hepatosplenomegaly and thrombocytosis. CT scan demonstrated calcified thrombus in inferior vena cava (IVC). Diagnosis of essential thrombocytosis was considered in view of persistent thrombocytosis, antiphospholipid antibodies, bone marrow showing increased number, clusters and giant forms of megakaryocytes and IVC thrombosis. He was started on warfarin prophylaxis and did not have thrombotic recurrence on follow up.
This is a preview of subscription content, log in via an institution to check access.
References
Dame C, Sutor AH. Primary and secondary thrombocytosis in childhood. Br J Haematol. 2005;129:165–77.
Campbell PJ, Green AR. Management of polycythemia vera and essential thrombocythemia. Hematol Am Soc Hematol Educ Program. 2005;1:201–8.
Jantunen R, Juvonen E, Ikkala E, et al. Essential thrombocythemia at diagnosis: causes of diagnostic evaluation and presence of positive diagnostic findings. Ann Hematol. 1998;77:101–6.
Harrison CN, Donohoe S, Carr P, et al. Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis. Thromb Haemost. 2002;87:802–7.
Ravelli A, Martini A. Antiphospholipid Syndrome. Pediatr Clin N Am. 2005;52:469–91.
Galli M, Luciani D, Bertolini G, et al. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood. 2003;101:1827–32.
Ortel TL. Thrombosis and the antiphospholipid syndrome. Hematol Am Soc Hematol Educ Program. 2005;1:462–8.
Senzolo M, Cholongitas EC, Patch D, et al. Update on the classification, assessment of prognosis and therapy of Budd–Chiari syndrome. Nat Clin Pract Gastroenterol Hepatol. 2005;2:182–90.
Horton JD, San Miguel FL, Ortiz JA. Budd Chiari syndrome: illustrated review of current management. Liver Int. 2008;28:455–68.
Pelletier S, Landi B, Piette JC, et al. Antiphospholipid antibody syndrome as the second cause of non-tumorous Budd-Chiari syndrome. J Hepatol. 1994;21:76–80.
Contributions
DY, JC: Diagnosis and management of patient, reviewed the literature and drafted the manuscript. SS, VS: Helped in diagnostic work up and critical review of the manuscript.
Conflict of Interest
None.
Role of Funding Source
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yadav, D., Chandra, J., Sharma, S. et al. Essential Thrombocytosis and Antiphospholipid Antibody Syndrome Causing Chronic Budd-Chiari Syndrome. Indian J Pediatr 79, 538–540 (2012). https://doi.org/10.1007/s12098-011-0550-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-011-0550-6